Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart ...

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

ST. LOUIS — Dr. Scally, a cardiothoracic surgeon with Prairie Cardiovascular in O’Fallon, Illinois, explains mitral valve disease, a condition that affects the mitral valve, which controls ...

Its total funding is more than $200 million. Cardiac Dimensions is targeting a condition called mitral valve regurgitation, which involves the leakage of blood through the heart’s mitral valve ...

The Duke team performed the world’s first living mitral valve replacement, a type of partial heart transplant, which Duke pioneered in 2022.